Asia's ascent - Global trends in biomedical R&D expenditures

New England Journal of Medicine

Volumn 370, Issue 1, 2014, Pages 3-6

  Chakma, Justin ^a   Sun, Gordon H ^b   Steinberg, Jeffrey D ^c   Sammut, Stephen M ^d   Jagsi, Reshma ^b  

^a Thomas McNerney and Partners   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^c AGENCY FOR SCIENCE   (Singapore)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASIA; CANADA; ECONOMIC DEVELOPMENT; EUROPE; FUNDING; GROSS NATIONAL PRODUCT; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; MEDICAL RESEARCH; NATIONAL HEALTH ORGANIZATION; ORGANIZATIONAL DOWNSIZING; ORGANIZATIONAL EFFICIENCY; PACIFIC ISLANDS; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; REVIEW; TREND STUDY; UNITED STATES; BUDGET; ECONOMICS; FINANCIAL MANAGEMENT; LEGISLATION AND JURISPRUDENCE; TRENDS;

ASIA; BIOMEDICAL RESEARCH; BUDGETS; FINANCING, GOVERNMENT; HEALTH EXPENDITURES; NATIONAL INSTITUTES OF HEALTH (U.S.); UNITED STATES;

EID: 84892147940     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1311068     Document Type: Article

References (5)

1. Sampat BN, Lichtenberg FR What are the respective roles of the public and private sectors in pharmaceutical innovation? Health Aff (Millwood) 2011;30:332-9.
2. Dorsey ER, de Roulet J, Thompson JP, et al Funding of US biomedical research, 2003-2008. JAMA 2010;303:137-43.
3. Collins FS. Fiscal Year 2014 budget request. Fiscal Year 2014 testimony before the Senate Subcommittee on Labor-HHS-Education Appropriations. May 15, 2013 (http://www.nih.gov/about/director/budgetrequest/fy2014testimony.htm).
4. Sun GH, Steinberg JD, Jagsi R. The calculus of national medical research policy - the United States versus Asia. N Engl J Med 2012;367:687-90.
5. Morgan S, Grootendorst P, Lexchin J., Cunningham C, Greyson D. The cost of drug development: a systematic review. Health Policy 2011;100:4-17.